Genetic overlap between depression and C-reactive protein levels: Evidence from a cross-trait analysis
Inflammation and depression have been consistently associated, with elevated C-reactive protein (CRP) levels observed in a significant subset of affected individuals. However, the genetic mechanisms underlying this association remain poorly understood. We integrated results from large-scale genome-wide association studies (GWAS) of depression and CRP levels in a cross-trait analysis specifically focusing on identifying horizontally pleiotropic loci. Identified variants were stratified as concordant versus discordant based on their direction of effects on the two traits and followed up using functional annotation, gene set enrichment, and colocalization analyses. We also explored causal relationships using Mendelian Randomization (MR) analysis with extensive sensitivity analyses, including adjustment for body mass index (BMI). We identified 9 novel loci. Functional analyses revealed that concordant loci were enriched in genes linked to immune and inflammatory processes, while discordant loci mostly mapped to metabolic pathways, including lipid regulation. MR provided strong evidence for body mass index driving a causal relationship between the genetic liability of depression on CRP levels. Our findings suggest that the association between depression and CRP levels is partly driven by shared genetic influences, pointing to different biological pathways depending on whether genetic effects are concordant or discordant. These results underscore the importance of considering effect direction when assessing the genetic overlap between depression and inflammatory processes. In addition, they highlight BMI as a key factor in the causal relationship between depression and systemic inflammation.
Authors
- Marta Ribasès (ORCID: https://orcid.org/0000-0003-1039-1116)
- Josep Antoni Ramos‐Quiroga (ORCID: https://orcid.org/0000-0003-1622-0350)
- Judit Cabana‐Domínguez (ORCID: https://orcid.org/0000-0002-4732-7284)
- María Soler Artigas (ORCID: https://orcid.org/0000-0002-3213-1107)
- Natalia Llonga (ORCID: https://orcid.org/0000-0003-4325-6201)
- Silvia Alemany (ORCID: https://orcid.org/0000-0002-7925-6767)
- Gara Arteaga-Henríquez (ORCID: https://orcid.org/0000-0002-1251-8988)
- Pau Carabí‐Gassol (ORCID: https://orcid.org/0000-0001-9105-2946)
- Valeria Macias‐Chimborazo (ORCID: https://orcid.org/0009-0002-8365-5098)
- Uxue Zubizarreta‐Arruti (ORCID: https://orcid.org/0009-0005-2267-6196)
- Manuel Donato Rodríguez-Romero (ORCID: https://orcid.org/0009-0004-5726-8259)
- Marta Graell
Institutions
- Universitat Autònoma de Barcelona (ES)
- Instituto de Salud Carlos III (ES)
- Centro de Investigación Biomédica en Red de Salud Mental (ES)
- Vall d'Hebron Institut de Recerca (ES)
- Vall d'Hebron Hospital Universitari (ES)
- Medical Research Network (US)
- Universitat de Barcelona (ES)
Publication Details
- Journal
- European Neuropsychopharmacology
- Published
- 2026-06-19
- DOI
- https://doi.org/10.1016/j.euroneuro.2026.112901
- Primary Topic
- Genetic Associations and Epidemiology
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Fundació la Marató de TV3
- Centro de Investigación Biomédica en Red de Salud Mental
- European College of Neuropsychopharmacology
- HORIZON EUROPE Framework Programme
- Agència de Gestió d'Ajuts Universitaris i de Recerca
- Instituto de Salud Carlos III
- European Regional Development Fund
- European Social Fund